LEADER 01574nas  2200553 a 450 
001 996203940803316
005 20240413020424.0
011   $a1179-1918
035   $a(OCoLC)37663865
035   $a(CKB)954925612980
035   $a(CONSER)  2011250650
035   $a(MiFhGG)2PMI
035   $a(MiAaPQ)38344
035   $a(DE-599)ZDB2043793-6
035   $a(EXLCZ)99954925612980
100   $a19970922a19959999  sy 
101 0 $aeng
135   $aurmnu|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aClinical drug investigation
210   $a[Mairangi Bay, Auckland, N.Z.] $cAdis International$d1995-
300   $aRefereed/Peer-reviewed
311   $a1173-2563 
606   $aDrugs$xTesting$vPeriodicals
606   $aPharmacology$vPeriodicals
606   $aDrugs$vPeriodicals
606   $aClinical Trials as Topic
606   $aDrug Evaluation
606   $aDrug Therapy
606   $aDrugs, Investigational.
606   $aInvestigational New Drug Application
606   $aPharmaceutical Preparations
608   $aPeriodical.
615  0$aDrugs$xTesting
615  0$aPharmacology
615  0$aDrugs
615  2$aClinical Trials as Topic.
615  2$aDrug Evaluation.
615  2$aDrug Therapy.
615  2$aDrugs, Investigational..
615  2$aInvestigational New Drug Application.
615  2$aPharmaceutical Preparations.
676   $a615
906   $aJOURNAL
912   $a996203940803316
996   $aClinical drug investigation$92405345
997   $aUNISA